Cipla completes acquisition of 100% stake in Inzpera Healthsciences

05 Dec 2025 Evaluate

Cipla has completed acquisition of 100% stake in Inzpera Healthsciences (Inzpera) on December 04, 2025. Accordingly, Inzpera has now become a wholly owned subsidiary of the Company.

The acquisition is a strategic move aimed at combining Inzpera’s extensive portfolio of paediatric pharmaceutical and wellness products with the company’s strong distribution network and operational capabilities to drive growth and scalability. Earlier, the company had entered into definitive agreements to acquire 100% stake in Inzpera Healthsciences.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Cipla Share Price

1374.50 2.95 (0.22%)
23-Jan-2026 10:21 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1628.90
Dr. Reddys Lab 1244.00
Cipla 1374.50
Zydus Lifesciences 890.90
Lupin 2151.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×